An athymic rat model of cutaneous radiation injury designed to study human tissue-based wound therapy by Lucas H Rifkin et al.
Rifkin et al. Radiation Oncology 2012, 7:68
http://www.ro-journal.com/content/7/1/68RESEARCH Open AccessAn athymic rat model of cutaneous radiation
injury designed to study human tissue-based
wound therapy
Lucas H Rifkin1, Strahinja Stojadinovic2, Collin H Stewart1, Kwang H Song2, Michael C Maxted1, Marcus H Bell3,
Natalie S Kashefi1, Michael P Speiser2, Michel Saint-Cyr1, Michael D Story3, Rod J Rohrich1, Spencer A Brown1
and Timothy D Solberg2*Abstract
Purpose: To describe a pilot study for a novel preclinical model used to test human tissue-based therapies in the
setting of cutaneous radiation injury.
Methods: A protocol was designed to irradiate the skin of athymic rats while sparing the body and internal organs
by utilizing a non-occlusive skin clamp along with an x-ray image guided stereotactic irradiator. Each rat was
irradiated both on the right and the left flank with a circular field at a 20 cm source-to-surface distance (SSD). Single
fractions of 30.4 Gy, 41.5 Gy, 52.6 Gy, 65.5 Gy, and 76.5 Gy were applied in a dose-finding trial. Eight additional
wounds were created using the 41.5 Gy dose level. Each wound was photographed and the percentage of the
irradiated area ulcerated at given time points was analyzed using ImageJ software.
Results: No systemic or lethal sequelae occurred in any animals, and all irradiated skin areas in the multi-dose trial
underwent ulceration. Greater than 60% of skin within each irradiated zone underwent ulceration within ten days,
with peak ulceration ranging from 62.1% to 79.8%. Peak ulceration showed a weak correlation with radiation dose
(r = 0.664). Mean ulceration rate over the study period is more closely correlated to dose (r = 0.753). With the highest
dose excluded due to contraction-related distortions, correlation between dose and average ulceration showed a
stronger relationship (r = 0.895). Eight additional wounds created using 41.5 Gy all reached peak ulceration above
50%, with all healing significantly but incompletely by the 65-day endpoint.
Conclusions: We developed a functional preclinical model which is currently used to evaluate human tissue-based
therapies in the setting of cutaneous radiation injury. Similar models may be widely applicable and useful the
development of novel therapies which may improve radiotherapy management over a broad clinical spectrum.
Keywords: Acute cutaneous radiation injury, Normal tissue toxicity, Kilovoltage x-ray irradiation, Immunodeficient
athymic rat model, Adipose-derived stem cellIntroduction
Radiation is an essential modality in the treatment of malig-
nancy, with over 60% of cancer patients receiving radiother-
apy. Advances in radiotherapy have improved outcomes and
resulted in higher rates of local control, contributing to a
13.6% overall reduction in cancer death rates between 1991
and 2004 [1]. Effective radiotherapy represents a dynamic* Correspondence: Timothy.Solberg@utsw.edu
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reproduction in any medium, provided the origbalance between maximizing tumor control and sparing of
healthy tissue. Nevertheless, treatment-resistant malignancies
may demand aggressive radiotherapy despite an increased
risk of normal tissue toxicity. In contemporary external
beam radiotherapy, the use of megavoltage photon energies
allows the majority of a dose to be delivered below the skin,
subjecting tumors to high levels of radiation while minimiz-
ing cutaneous damage. However, skin-sparing may be
reduced or even lost due to oblique beam angles, carbon
fiber tables, or contamination of the beam with electrons
and low-energy photons. Clinicians must carefully considertd. This is an Open Access article distributed under the terms of the Creative
mmons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
inal work is properly cited.
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pact the skin response, as outcomes of radiotherapy are
often determined by characterizing the severity and the
onset of radiation skin toxicity. Skin can be a dose-limiting
tissue for certain cancer patient populations, such as tumors
of the breast, head, and neck. In these sites, cutaneous radi-
ation injury is one of the major concerns. Close proximity of
skin to the surgical cavity often excludes patients from pur-
suing brachytherapy treatments such as accelerated partial
breast irradiation (APBI) using balloon applicators. Recently,
a prospective clinical study to evaluate APBI was closed early
due to cutaneous injury [2]. Although treatment plans
adhered to dosimetric requirements of the national APBI
trial, 7 out of 34 patients developed new and unacceptable
cosmetic outcomes.
In general, the human skin response to ionizing ra-
diation is highly complex and dependent on the con-
ditions of the exposure [3]. Early effects are
characterized by damage to the epidermis, while late
effects arise from insult to the dermal vasculature.
Acute changes begin within hours as a transient ery-
thema which subsides after 1 to 2 days, while a more
intense erythematous reaction follows. Within 3 to 6
weeks, dry and moist desquamation may occur with a
secondary ulceration possible 6 weeks or longer there-
after. Between 8 and 16 weeks, dermal ischemia and
dermal necrosis may result in another erythematous
phase. Late skin damage begins with dermal atrophy
as early as 6 months, with telangiectasia and invasive
fibrosis following after 1 year or longer. In clinical
radiotherapy practice, skin necrosis and telangiectasia
are two endpoints used to maintain the standard of
care, with a 5-year 50% complication rate estimated
to occur at doses of 65 Gy for telangiectasia and 70
Gy for necrosis [4]. The presentation of radiation-
induced skin damage varies across animal models, but
the underlying mechanism of injury and pathologic
changes are similar to human tissue. In animal mod-
els there is a plethora of data on skin tolerance,
largely from the era predating medical accelerators
using megavoltage energies [5-16].
Current treatments and research [17,18] for cutaneous
radiation damage are limited, but future discoveries may
provide therapies which revitalize affected tissue and
ameliorate the progressive deterioration of skin. This
publication describes the design of a novel protocol to
apply x-ray radiation to the skin of athymic rats. A
multi-dose trial is followed by more extensive testing of
a single dose. The end result is a functional preclinical
model which is now used to test human tissue-based
therapies in the setting of cutaneous radiation injury.
Such treatments could be widely applicable, easily admi-
nistered, and could significantly improve radiotherapy
management over a broad clinical spectrum.Materials and methods
Image guided stereotactic irradiator
An x-ray image guided stereotactic irradiator was
designed for small animal studies. The characteristics
and evaluation of the image guidance system are
described in more detail in other articles [19-22]. In
brief, main components include a commercial x-ray de-
vice (XRAD 320, Precision X-Ray Inc., N. Branford, CT),
a custom-built collimation system, and an image guid-
ance system. The XRAD 320 has a tube current ranging
from 0.1 to 45 mA and a tube potential ranging from 5
to 320 kVp, permitting both diagnostic and therapeutic
applications. The collimation system is based on a 20
mm diameter collimator mounted beneath the x-ray
tube. The collimator is 25.4 mm thick, effectively elimin-
ating transmitted radiation. Copper-tungsten alloy
inserts can be placed within the collimator to reduce
beam diameter, but none were used in this study. The
imaging system includes a high resolution x-ray intensi-
fying screen (Kodak Min-R2, Rochester, NY) which con-
verts x-rays reaching the screen into visible light forming
an image captured by a commercial CCD camera. The
imaging device resolution and contrast were sufficient to
clearly display anatomic structures in a small animal. For
image guidance, a tube potential of 30 kVp and tube
current of 10 mA were used. Target localization began
by placing the animal in the irradiator and acquiring a
pre-localization image. Next, animal position was
adjusted using a manual XY linear translation stage
coupled to the bed. Another reference image confirmed
the animal position relative to the central beam axis.
Animal preparation and irradiation
A protocol was designed to irradiate the skin of athymic
rats while sparing the body and internal organs from sig-
nificant damage, the setup is shown in Figure 1. The
loose lateral skin was gently pulled away from the body
and held outward in a clamp. The clamp was con-
structed from two acrylic sheets with the gripping sur-
face lightly abraded to increase friction. Acrylic spacers
maintained the distance between the sheets to at least
1.8 mm to prevent vascular occlusion and crush injury.
The clamp contained six holes of 1 mm diameter drilled
through both sheets along the border of a 20 mm diam-
eter semicircle. The six radiolucent holes were visible
throughout the image guidance process and provided
outline of the skin to be irradiated. As indicated in Fig-
ure 1, the three holes forming the diameter of the semi-
circle were aligned with the edge of folded skin. Next,
the x-ray beam was made coincident with the radio-
lucent holes using the image guidance system. Due to
geometric divergence, the beam diameter at treatment
distance was slightly larger (26.6 mm) than the diameter
of the collimator (20 mm).
Figure 1 Schematic of rat irradiation. Under anesthesia, skin was
held outward in an acrylic clamp and exposed to x-ray radiation. The
beam was centered on the skin edge, traversing a semicircular skin
fold. As a result, a circular area of skin was irradiated.
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were irradiated at eight weeks of age and at an average
mass of 180 grams. This strain athymic nude rat is T-cell
deficient and shows depleted cell populations in thymus-
dependent areas of peripheral lymphoid organs. Each rat
was irradiated twice, once on the left side and once on
the right side using the same dose. Each skin site was
irradiated at 250 kVp and 15 mA with the addition of
1.65 mm Al filtration to remove low energy photons
from the beam at a 20 cm source-to-surface distance
(SSD). The irradiator was calibrated following the AAPM
Task Group 61 protocol [23], as a result the dose rate at
the surface of the animals was determined to be 18.43
Gy/min with an inherent 2.9 s shutter timing error. The
irradiation times were: 1.7 min, 2.3 min, 2.9 min, 3.6
min, and 4.2 min, resulting in respective doses of 30.4
Gy, 41.5 Gy, 52.6 Gy, 65.5 Gy, and 76.5 Gy. Following
the multi-dose study, eight additional wounds were cre-
ated using the 41.5 Gy dose. Rats were housed individu-
ally to prevent gnawing of wounds and other potentially
damaging interactions.
In the multi-dose study, irradiation was followed by
the placement of tattoo marks demarcating the border
of the affected skin area. With the clamp still attached,ink was applied to skin by placing a needle through the
semicircular pattern of holes in both sides of the clamp.
A circular pattern outlining the irradiated zone was cre-
ated along with an additional mark at its center. No
tattooing was performed during the subsequent eight-
wound 41.5 Gy experiment.
Wound analysis
Rats in the initial multi-dose trial were photographed on
days 0 to 10 post-irradiation and on even-numbered days
from 10 to 100. The eight additional 41.5 Gy wounds
were photographed on each day from 0 to 15 and on
each odd-numbered day from 15 to 65. Multiple images
of each wound were obtained and a single best image
was selected based on lighting, focus, angle, and clarity
of the wound area. The percentage of the irradiated area
ulcerated at each time point was determined utilizing
ImageJ version 1.42 (NIH, Bethesda, MD), a public do-
main Java image processing and analysis software.
Blinded volunteers outlined the borders of the total irra-
diated area and the ulcerated area, examples are shown
in Figure 2. The irradiated area was distinguished from
unaffected areas based on hair loss within the irradiated
area and other differences in skin appearance. The ulcer-
ated area was defined as any skin affected by scabbing,
crusting, or desquamation. The number of pixels within
each zone was calculated using ImageJ, and these counts
were used to calculate the percentage of skin within the
irradiated zone which was ulcerated at any given time.
Figure 2 illustrates this methodology by plotting ulcer-
ation over time using a single example wound along with
photographs corresponding to select time points.
Animal care and euthanasia
For all procedures, anesthesia was induced using an intraper-
itoneal injection of ketamine, xylazine, and acepromazine at
50 mg/kg, 25 mg/kg, and 1 mg/kg, respectively. Following
anesthesia, rats were placed on a heating pad and monitored
until they were ambulatory. Study animals were euthanized
using an intraperitoneal injection of pentobarbital at 100
mg/kg. All animal procedures were performed according to
local and National Institutes of Health guidelines and
approved by the University of Texas Southwestern Institu-
tional Animal Care and Use Committee.
Results
Multi-dose trial
No systemic or lethal sequelae occurred in any study ani-
mals. All irradiated skin areas underwent significant ul-
ceration, with greater than 60% of skin within each
irradiated zone having ulcerated after ten days. The peak
ulceration levels ranged from 62.1% to 79.8%, as shown
in Table 1. Peak ulceration showed a weak correlation
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Figure 2 An example of one rat wound created using a 41.5 Gy dose. The selected images show the ulceration region within the area of
irradiated skin. ImageJ software was used to calculate the ulceration percentage. All data in this figure represent the same wound at different
time points.
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each wound, which is more closely correlated to dose
(r = 0.753). When the 76.5 Gy dose was excluded due to
contraction-related distortion, correlation between dose
and average ulceration during the study was stronger
(r = 0.895).
During the first ten days, wounds in all five dose
groups shared a similar appearance. By day five, all
affected areas clearly displayed the acute effects of ery-
thema, mild dryness, and hair loss. By day seven, areas of
intense reaction had appeared, found most prominentlyTable 1 Ulceration data for five rats in the multi-dose trial, ar
Peak Ulcera
30.4 Gy 41.5 Gy














30.4 Gy 41.5 Gy
Left Right Left Right L
19.5% 2.6% 44.8% 17.6% 4
Each rat was wounded twice, once on the left side and once on the right side using
62% ulceration, yet no wound exceeded 80% ulceration. Second part of the table sh
day 100 (sacrifice).near tattoo marks. The eighth day was characterized by
patchy scaling and increasing dryness. On the ninth day,
skin reactions intensified markedly, see Figure 3A. The
close resemblance among all wounds in the multi-dose
trial was no longer present by day 12, as each wound in
the 30.4 Gy and 41.5 Gy groups had a distinct appear-
ance. Meanwhile, the majority of each zone irradiated
with doses of 52.6 Gy, 65.5 Gy, and 76.5 Gy had fully
desquamated. Through the fourth week, the higher dose
(≥ 52.6 Gy) wounds shared similar features and, under-
went only minimal changes in appearance. Figure 3Branged by dose level.
tion Percentage: Days 10-100
52.6 Gy 65.5 Gy 76.5 Gy
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the same dose. The peak ulceration level for all ten wounds reached at least
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Figure 3 The appearance of irradiated areas throughout the 80-day period. The photographs are for five rats, one rat for each dose level.
Each rat was wounded twice, once on the left side and once on the right side using the same dose. A. By day 9, erythema predominated within
all irradiated areas. Crusting and desquamation were beginning to develop. Reactions intensified quickly, yet displayed a relatively uniform wound
appearance across the entire dose range. Areas of increased reactivity were visible surrounding tattoo marks. B. By day 24, lower dose wounds
(30.4 Gy and 41.5 Gy) each had a distinctly different appearance, while higher dose wounds (52.6 Gy to 76.5 Gy) exhibited features similar to other
higher dose wounds. A 30.4 Gy wound had healed completely by day 20, accompanied by the return of hair growth in the irradiated area. Both
41.5 Gy wounds had undergone dry desquamation. Higher dose wounds displayed varying degrees of moist desquamation surrounded by
intense crusting at the borders. C. By day 54, contraction in the 76.5 Gy wounds has significantly reduced the overall area of irradiated skin as well
as the enclosed area of ulceration. A relatively low level of contraction was seen in the 65.5 Gy wounds. D. By day 80, contraction is apparent in
the 65.5 Gy wounds, but impacts area and shape to a lesser degree than the higher dose. In the 76.5 Gy rat, contraction has distorted the
irradiated area to such an extent that it has little resemblance to its original circular shape.
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on day 24, which resembles the consistent appearance
seen from day 12 through day 28.
Wound contraction occurred within all areas irra-
diated with 52.6 Gy and higher doses. One additional
41.5 Gy wound underwent contraction, but only after
the 80th day and to a minute degree. Neither of 30.4
Gy wounds contracted. Distortion in the shape and
size of wounds ranged from minimal to severe. With
increased dose, contraction began earlier and occurred
with increased intensity. As contraction progressed,
the dimension of irradiated areas was reduced from
an anterior to posterior direction while the distance
between the superior and inferior borders remained
constant. Contraction began earliest and was most se-
vere in the highest dose 76.5 Gy group. Figure 3C-3D
illustrates the extreme contraction distinguishing this
group from the 65.5 Gy and lower dose groups. Fig-
ure 4 presents photographs obtained on the final ex-
perimental day.Eight-wound validation with 41.5 Gy dose
Following the multi-dose trial, eight additional rats
received radiation dose of 41.5 Gy. Neither systemic
effects nor organ damage were observed. The earliest
images analyzed at day 15 had ulceration percentages
ranging from 48.8% to 72.2% with a mean of 59.6% and
standard error of mean (SEM) of 3.0%. No rats healed
completely by the experimental endpoint at day 65. Final
ulceration percentage ranged from 5.8% to 47.0% with a
mean of 29.1% and SEM of 4.6%. Healing progression in
this group is presented in Figure 5.
The eight wounds from the 41.5 Gy dose validation ex-
periment and the trial wounds irradiated using the same
dose displayed similarities with respect to the progression of
healing, see Figure 6. All eight developed irregular margins
soon after ulceration had peaked. Scabbing, crusting, and
dry desquamation were observed throughout irradiated
areas unlike the higher dose (≥ 52.6 Gy) trial wounds. None
of the additional 41.5 Gy wounds contracted or developed












Wound #1 (Left) Wound #2 (Right)
Figure 4 Photographs obtained on the final day of the study
for five rats, one rat for each dose level. Significant contraction is
visible in all wounds created using doses of 52.6 Gy and higher.
Contraction is seen to a lesser degree on one wound (left) created
using the 41.5 Gy dose. Hair growth has resumed within areas
irradiated using a 30.4 Gy dose.
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The multi-dose trial established a protocol to safely and
reliably deliver cutaneous x-ray radiation to athymic rats
without causing systemic effects. However, the trial samplesize was insufficient to rule out the possibility of adverse
events within the tested range. Subsequent experiments
involved eight skin areas irradiated with a 41.5 Gy dose
and followed for 65 days. Ulceration occurred in the ma-
jority of each affected area and systemic damage was not
observed, establishing safety of the model at this dose. A
41.5 Gy dose was selected because it produced moderate
skin damage with minimal early contraction. Furthermore,
doses higher than or lower than 41.5 Gy may be less com-
patible with wound healing research. The 30.4 Gy dose
caused mild injuries which had the capacity to resolve as
early as 20 days post-irradiation without intervention.
Studying wounds which do not last long enough to allow a
treatment to exert its effect could result in a failure to de-
tect an existing therapeutic benefit. At 52.6 Gy and higher
doses, early contraction could complicate wound analysis
and higher doses may cause excessive insult to cell viabil-
ity. Wounds in higher dose groups contained moist des-
quamation centrally, while scabbing and crusting were
limited to margins. Higher doses may have caused exten-
sive destruction to epidermal basal cells decreasing cellular
function within borders, causing a breakdown in skin in-
tegrity which permitted fluid to traverse barriers and pro-
duce moist desquamation. In the 30.4 Gy and 41.5 Gy
groups, cellular function may have persisted to a degree
sufficient to allow crusting and other signs of underlying
healing processes to occur within central wound areas.
Moderate doses may allow viable cells to remain so
that restorative therapies can produce an observable
benefit. However, if cellular function is eliminated be-
yond recovery, demonstrating the efficacy of treatments
which revitalize moderately depleted or weakened cell
populations may be elusive. Withers et al. [5] developed
a technique to assess viability of irradiated cells in vivo,
this method may be helpful to illustrate the relationship
between x-ray dose and the extent of cell survival in
athymic rats.
As dose was increased, contraction began sooner and
occurred to a greater extent, with striking differences
observed between the 65.5 Gy and 76.5 Gy groups, as
seen in Figure 3C. Contraction in the 76.5 Gy dose
caused profound distortion in the shape and size of the
total irradiated area and its ulcerated subset. Ulceration
in this group resolved more quickly than in the 65.5 Gy
dose, likely a result of reduction in the ulcerated area by
means of contraction-related shrinking of the overall
irradiated zone. As the size of the treated zone was
reduced, some of the ulcerated skin area within was
eliminated. Rather than healing, the damaged skin’s area
decreased, it was not replaced with healthy tissue. Con-
traction in the 65.5 Gy and 52.6 Gy groups appeared
later and was less extreme. The 41.5 Gy group showed
no visible contraction until after the 80th day, and no






















Figure 5 Healing progression of eight rats, each with one wound created using a 41.5 Gy dose. By day 65 post-irradiation, all wounds
healed significantly but ulceration remained within 5.8% to 47.0% of each irradiated zone.
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ImageJ-based ulceration percentages reflects the relation-
ship among the true areas of the ulcerated skin zones. This41.5 G
y
Day 19
Figure 6 Four rats’ wounds in the additional group irradiated
with 41.5 Gy. Appearance was similar to 41.5 Gy wounds in the
multi-dose trial, without tattooing. Borders were irregular rather than
maintaining a smooth, circular shape. Scabbing, crusting, and signs
of healing were observed throughout wounds.proportional relationship is founded on irradiation of equal-
sized skin patches and can be maintained only if the relative
size and shape of treated areas remains consistent. If con-
traction distorts an irradiated area, the ImageJ-calculated
ulceration percentage, i.e., assessing the ratio of ulcerated
area and total irradiated area, becomes futile. Therefore,
avoiding contraction is of critical importance when this
analysis is used as an endpoint. The 76.5 Gy dose caused
marked contraction, so the ulceration percentage from this
group was of little value.
The current study provides a preclinical model to
study late effects or various levels of radiation damage,
which could also be modified to incorporate fractionated
dosing. By building on the general patterns of dosage
and healing described in this study, researchers may
individualize their protocol to create wounds suitable for
their specific aims. The next step envisioned for this
model system is to explore the ability of human lipoaspi-
rate grafts and adipose-derived stem cell-enriched grafts
to improve healing in acute radiation injuries.
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